Vivos Inc (RDGL)

[CatfishHunter]

At this point, wether human clinical trials are or will be needed for FDA approval for human use is a non issue. The Vet side is the current driving force and determining factor. If Radiogel for Vet side goes to market and starts generating revenue, it's a whole new game as huge amounts of financial support will come in, allowing FDA process for approval in humans to continue to completion. If Radiogel for Vet use doesn't get to market, then the company is dead in the water. And if Korenko's promise holds true of vet revenue in October or even November, this will easily run over 10 cents. .25-.50 more likely.

Giddyup RDGL!!!